featured
Short- and Long-Term Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The American Journal of Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
Am. J. Gastroenterol 2023 Jul 01;118(7)1237-1247, M Chaparro, D Acosta, C Rodríguez, F Mesonero, M Vicuña, M Barreiro-de Acosta, A Fernández-Clotet, Á Hernández Martínez, M Arroyo, I Vera, A Ruiz-Cerulla, B Sicilia, MJ Cabello Tapia, C Muñoz Villafranca, J Castro-Poceiro, J Martínez Cadilla, M Sierra-Ausín, JM Vázquez Morón, R Vicente Lidón, F Bermejo, V Royo, M Calafat, C González-Muñoza, E Leo Carnerero, N Manceñido Marcos, L Torrealba, H Alonso-Galán, JM Benítez, Y Ber Nieto, MT Diz-Lois Palomares, MJ García, JF Muñoz, EM Armesto González, X Calvet, A Hernández-Camba, RE Madrigal Domínguez, L Menchén, JL Pérez Calle, M Piqueras, C Dueñas Sadornil, B Botella, TJ Martínez-Pérez, L Ramos, MC Rodríguez-Grau, E San Miguel, JL Fernández Forcelledo, PM Fradejas Salazar, M García-Sepulcre, A Gutiérrez, J Llaó, E Sesé Abizanda, M Boscá-Watts, E Iyo, A Keco-Huerga, C Martínez Bonil, E Peña González, P Pérez-Galindo, P Varela, JP GisbertFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.